Reactivating the Epstein-Barr virus (EBV).
New research shows that preventing one infection after stem cell transplants could trigger another. Patients receiving treatment to stop CMV infections may have a higher risk of reactivating the Epstein-Barr virus (EBV).
Umbilical cord mesenchymal stem cells in ulcerative colitis treatment: efficacy and possible mechanisms
Recent advancements highlight the potential of umbilical cord mesenchymal stem cells (UC-MSCs) in treating ulcerative colitis. This study explores their efficacy and underlying mechanisms, offering hope for a novel therapeutic approach.
